Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Clinical trial NCT00217555 · COMPLETED
Trial details
- NCT number
- NCT00217555
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2006-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.